Stones: Evaluation and Medical Management: Difference between revisions

Line 264: Line 264:
*** '''Phosphate therapy is contraindicated in cases of infection calculi because this medication may promote further stone formation.'''
*** '''Phosphate therapy is contraindicated in cases of infection calculi because this medication may promote further stone formation.'''


===== '''Medical management of pediatric calculi''' =====
=== Medical management of pediatric calculi ===


* '''Neonates can develop furosemide-induced nephrolithiasis.'''
* '''Neonates can develop furosemide-induced nephrolithiasis.'''
Line 273: Line 273:
* There is a lack of consensus regarding normal laboratory values during 24-hour urine collections in children. Clinicians have relied on ratios to correct for the wide variation of weight
* There is a lack of consensus regarding normal laboratory values during 24-hour urine collections in children. Clinicians have relied on ratios to correct for the wide variation of weight
* '''The medical management of nephrolithiasis and the prevention of subsequent recurrences in children do not differ that dramatically from the approaches undertaken for adults'''
* '''The medical management of nephrolithiasis and the prevention of subsequent recurrences in children do not differ that dramatically from the approaches undertaken for adults'''
 
== Questions ==
 
===== Questions =====


# What is the risk of stone recurrence at 10 years in first-time stone formers?
# What is the risk of stone recurrence at 10 years in first-time stone formers?
# What is the microscopic appearance of common urinary calculi?
# What is the microscopic appearance of common urinary calculi?


===== Answers =====
== Answers ==
1. 50%
1. 50%


===== References =====
== References ==


* Wein AJ, Kavoussi LR, Partin AW, Peters CA (eds): CAMPBELL-WALSH UROLOGY, ed 11. Philadelphia, Elsevier, 2015, chap 52
* Wein AJ, Kavoussi LR, Partin AW, Peters CA (eds): CAMPBELL-WALSH UROLOGY, ed 11. Philadelphia, Elsevier, 2015, chap 52